Effects of Montelukast and Salmeterol on Physical Performance and Exercise Economy in Adult Asthmatics With Exercise-Induced Bronchoconstriction
Authors:
- Sigurd SteinshamnSSSigurd Steinshamn
- Mariann SandsundMSMariann Sandsund
- Malcolm Sue-ChuMSMalcolm Sue-Chu
- Leif BjermerLBLeif Bjermer
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise‐induced bronchoconstrictionScandinavian Journal of Medicine & Science in Sports, 2002
- The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterolRespiratory Medicine, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma*Clinical Pharmacology & Therapeutics, 1997
- Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4receptor antagonistCanadian Journal of Physiology and Pharmacology, 1995
- Prolonged Effect of Inhaled Salmeterol against Exercise-Induced BronchospasmAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Effects of salbutamol inhalations on transcutaneous blood gases in children during the acute asthmatic attack: from acute deterioration to recoveryActa Paediatrica, 1994
- Prevention of Exercise-induced Bronchoconstriction by a New Leukotriene Antagonist (SK&F 104353): A Double-Blind Study Versus Disodium Cromoglycate and PlaceboAmerican Review of Respiratory Disease, 1992
- Ventilation-Perfusion Distributions and Central Hemodynamics in Chronic Obstructive Pulmonary DiseaseChest, 1989
- Specificity of exercise in exercise-induced asthma.BMJ, 1971